We’re thrilled to share that on Nov 12^th, the IMF announced the appointment of Yelak Biru as their new CEO, replacing Susie Durie. Diagnosed with myeloma in 1995 at the age of 25, Yelak is a strong patient and research advocate and served as Patient Advocate on the IMF Board of Directors. Read more on Yelak here.

Myeloma Canada has always enjoyed a very positive and collaborative relationship with the IMF and Susie – Martine Elias, our Executive Director – sits on their Board of Directors. With Yelak’s appointment, we know this will continue to grow strong. Yelak is a great friend and supporter of our organization – some of you may remember his presentation at our 2019 Support Group Leaders’ Summit – we couldn’t be more thrilled for him.

There is no doubt Yelak will be a great addition to the IMF’s leadership and for all those living with myeloma around the world!

Read the official letter of Myeloma Canada

Read the press release here